Catto, J., Hartmann, A., Stoehr, R., Bolderson, E., Rehman, I., Rosario, D., . . . Meuth, M. (2006). Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.
Chicago-čujuhus (17. p.)Catto, J., A. Hartmann, R. Stoehr, E. Bolderson, I. Rehman, D. Rosario, F. Hamdy, juo M. Meuth. Multifocal Urothelial Cancers with the Mutator Phenotype Are of Monoclonal Origin and Require Panurothelial Treatment for Tumor Clearance. 2006.
MLA-čujuhus (9. p.)Catto, J., et al. Multifocal Urothelial Cancers with the Mutator Phenotype Are of Monoclonal Origin and Require Panurothelial Treatment for Tumor Clearance. 2006.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.